Partnership Opportunities
With a laser focus on analytical development for cell therapies, the 7th Cell Therapy Analytical Development Summit offers a uniquely specialized platform unmatched by broader cell and gene therapy meetings. Unlike other events that dilute attention across multiple manufacturing and R&D disciplines, this summit delivers a program 100% dedicated to overcoming the technical, regulatory, and scalability challenges in assay design, qualification, and validation, from preclinical through commercialization.
We will bring together hands-on analytical development experts, ensuring your brand is in front of the people directly using your solutions, and those looking to make technology and purchasing decisions. Don't miss the opportunity to position your solutions at the center of the industry, as they solve its most pressing analytical bottlenecks.
A Quick Audience Breakdown:
Take a quick look at our exclusive blind attendee list which breaks down the companies, job titles and expertise of those in attendance in 2025.
Companies include Genentech, Bayer, Takeda, Vertex Pharmaceuticals Bristol Myers Squibb, Retro Biosciences and Astellas Pharma.
Job titles include Vice Presidents, Directors, Heads and Scientists of Analytical Development, Quality Control, Assay Development and more.
Our Current Partners:
Lead Partner
Official Partners
Analytical Experts Need Your Support to:
Develop and qualify robust, scalable potency and release assays that meet evolving US and wider regulatory expectations
Implement rapid, reliable sterility and mycoplasma testing methods to accelerate turnaround times without compromising quality
Transfer complex analytical methods seamlessly between internal teams and CMOs while maintaining reproducibility
Integrate advanced analytical platforms for deeper characterization, including cellular kinetics, immunophenotyping, and genomic profiling.
Why is Partnering Your Key to 2025 Success & Beyond?
Engage with the Top Cell Therapy Analytical Pioneers: Connect with senior quality control, CMC, and analytical development professionals from industry-leading biotechs, pharma, and academic institutions.
Align Your Solutions with the Latest Industry Innovations: Showcase how your technologies and services support breakthrough analytical methods, assay validation, and streamlined regulatory approval in this fast-evolving field.
Shape the Future of Cell Therapy Analytics: Participate in critical discussions focused on regulatory trends, assay standardization, and scalable workflows, to position your brand at the forefront of the cell therapy analytical development community.
Audience Graphs:
*Statistics taken from the 6th Cell Therapy Analytical Development Summit
Get in Touch:
Interested in Exploring Related Cell Therapy Events?
Introducing the Cell Therapies Event Series, a collection of 16 established events curated to enable this community to achieve their clinical and commercial potential.
